What is Optain?
Optain Health is a global medical technology company that specializes in AI-driven retinal imaging solutions. Its core innovation lies in a platform that employs advanced artificial intelligence algorithms to analyze retinal images. This capability enables the early identification of a wide spectrum of eye diseases, as well as systemic health conditions, positioning Optain at the forefront of preventative healthcare technology.
How much funding has Optain raised?
Optain has raised a total of $38M across 2 funding rounds:
Angel/Seed
$12M
Series A
$26M
Angel/Seed (2023): $12M, investors not publicly disclosed
Series A (2025): $26M led by Insight Partners
Key Investors in Optain
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.
What's next for Optain?
With the infusion of $26M from a major strategic investment, Optain is poised for accelerated growth and further development of its AI-driven diagnostic platform. This enterprise-level funding suggests a focus on scaling operations, expanding market reach, and potentially enhancing its research and development initiatives to broaden the scope of detectable diseases. The company's trajectory indicates a strong emphasis on solidifying its market leadership in the competitive medtech landscape.
See full Optain company page
